Cargando…
Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488185/ https://www.ncbi.nlm.nih.gov/pubmed/25851380 http://dx.doi.org/10.1007/s40268-015-0091-y |
| _version_ | 1782379112434761728 |
|---|---|
| author | Frevert, Jürgen |
| author_facet | Frevert, Jürgen |
| author_sort | Frevert, Jürgen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4488185 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44881852015-07-02 Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products Frevert, Jürgen Drugs R D Letter to the Editor Springer International Publishing 2015-04-08 2015-06 /pmc/articles/PMC4488185/ /pubmed/25851380 http://dx.doi.org/10.1007/s40268-015-0091-y Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter to the Editor Frevert, Jürgen Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products |
| title | Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products |
| title_full | Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products |
| title_fullStr | Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products |
| title_full_unstemmed | Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products |
| title_short | Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products |
| title_sort | response to commentary by w. jost on: pharmaceutical, biological, and clinical properties of botulinum neurotoxin type a products |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488185/ https://www.ncbi.nlm.nih.gov/pubmed/25851380 http://dx.doi.org/10.1007/s40268-015-0091-y |
| work_keys_str_mv | AT frevertjurgen responsetocommentarybywjostonpharmaceuticalbiologicalandclinicalpropertiesofbotulinumneurotoxintypeaproducts |